.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Deloitte
Dow
Cipla
Baxter
Medtronic
Moodys
Julphar
US Department of Justice

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008708

« Back to Dashboard

NDA 008708 describes DIBENZYLINE, which is a drug marketed by Concordia Pharms Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the DIBENZYLINE profile page.

The generic ingredient in DIBENZYLINE is phenoxybenzamine hydrochloride. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.

Summary for 008708

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 008708

Mechanism of ActionAdrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for 008708

Suppliers and Packaging for NDA: 008708

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIBENZYLINE phenoxybenzamine hydrochloride CAPSULE;ORAL 008708 NDA Concordia Pharmaceuticals Inc. 59212-001 59212-001-01 100 CAPSULE in 1 BOTTLE (59212-001-01)
DIBENZYLINE phenoxybenzamine hydrochloride CAPSULE;ORAL 008708 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-066 66993-066-02 100 CAPSULE in 1 BOTTLE (66993-066-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
QuintilesIMS
Deloitte
Federal Trade Commission
UBS
Express Scripts
Accenture
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot